NIAGEN BIOSCIENCE, INC.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|
| Revenue | $21.2M | $21.7M | $15.3M | $10.2M | $11.6M | $8.1M |
| Cost of Revenue | $10.7M | $11.3M | $10.0M | $7.0M | $9.3M | $5.6M |
| Gross Profit | $10.5M | $10.4M | $5.3M | $3.1M | $2.3M | $2.5M |
| Gross Margin | 49.4% | 48.0% | 34.8% | 30.8% | 19.6% | 30.5% |
| Operating Expenses | ||||||
| Research & Development | $4.0M | $2.5M | $513.7K | $134.0K | $142.0K | $96.8K |
| SG&A Expense | $17.6M | $9.2M | $7.9M | $5.0M | $8.4M | $7.8M |
| Operating Income | $-16.4M | $-2.9M | $-5.2M | $-4.4M | $-11.6M | $-7.9M |
| Operating Margin | -77.2% | -13.4% | -34.2% | -43.2% | -100.2% | -96.9% |
| Interest Expense | $153.0K | $333.3K | $158.8K | $34.3K | $29.0K | $-32.1K |
| Pretax Income | $-16.5M | $-3.6M | $-5.4M | $-4.4M | — | — |
| Income Tax Expense | $0 | $0 | $0 | — | — | — |
| Net Income | $-11.4M | $-2.9M | $-5.4M | $-4.4M | $-11.7M | $-7.9M |
| Net Margin | -53.7% | -13.5% | -35.2% | -43.5% | -100.4% | -97.3% |
| EPS (Basic) | $-0.26 | $-0.08 | $-0.15 | $-0.04 | $-0.13 | $-0.12 |
| EPS (Diluted) | $-0.26 | $-0.08 | $-0.15 | $-0.04 | $-0.13 | $-0.12 |
| Shares Outstanding (Basic) | 54.7M | 37.3M | 35.5M | 100.0M | 90.3M | 68.3M |
| Shares Outstanding (Diluted) | 54.7M | 37.3M | 35.5M | 100.6M | 96.0M | 76.0M |
| Dividends Per Share | — | — | — | — | — | — |